What was the first non-steroidal immunosuppressive drug that significantly increased heart transplant success rates?

What was the first non-steroidal immunosuppressive drug that significantly increased heart transplant success rates?

• A. Penicillin
• B. Cyclosporine
• C. Tacrolimus
• D. Azathioprine

Answer: (B)

Cyclosporine is recognized as the first non-steroidal immunosuppressive drug that notably improved the success rates of heart transplants. Introduced in the early 1980s, cyclosporine revolutionized the field of organ transplantation by effectively suppressing rejection of transplanted organs. Prior to its use, transplant success rates were much lower, primarily due to the body’s immune response rejecting the transplanted tissue. Cyclosporine works by selectively inhibiting T-lymphocyte activation and proliferation, which is crucial in the immune response against transplanted organs. This targeted action contributed to a significant reduction in acute rejection episodes, allowing for better short-term outcomes following heart transplants. The other drugs listed, such as penicillin, azathioprine, and tacrolimus, either do not fit the criteria as a first significant breakthrough in heart transplants or represent different classes of immunosuppressants. While azathioprine was one of the earlier immunosuppressants used in transplantation, it is a steroidal agent, making it different from the context of non-steroidal options. Tacrolimus, while an important advancement in immunosuppressive therapy post-cyclosporine, came later and built

Cyclosporine is recognized as the first non-steroidal immunosuppressive drug that notably improved the success rates of heart transplants. Introduced in the early 1980s, cyclosporine revolutionized the field of organ transplantation by effectively suppressing rejection of transplanted organs. Prior to its use, transplant success rates were much lower, primarily due to the body’s immune response rejecting the transplanted tissue.

Cyclosporine works by selectively inhibiting T-lymphocyte activation and proliferation, which is crucial in the immune response against transplanted organs. This targeted action contributed to a significant reduction in acute rejection episodes, allowing for better short-term outcomes following heart transplants.

The other drugs listed, such as penicillin, azathioprine, and tacrolimus, either do not fit the criteria as a first significant breakthrough in heart transplants or represent different classes of immunosuppressants. While azathioprine was one of the earlier immunosuppressants used in transplantation, it is a steroidal agent, making it different from the context of non-steroidal options. Tacrolimus, while an important advancement in immunosuppressive therapy post-cyclosporine, came later and built